Search Results 101-110 of 18899 for B cell lymphomas

  1. Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia - Mayo Clinic

    ... lymphoma or B-cell acute leukemia. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells, by ...

  2. Publications - Javier L. Munoz, M.D., M.B.A. - Mayo Clinic

    ... B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium. Clin Lymphoma Myeloma Leuk. 2022 Oct; 22 (10):753-759 Epub 2022 May 23. View PubMed; Munoz JL ...

  3. A Randomized, Open-label Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy after Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma - Mayo Clinic

    Primary mediastinal large B cell lymphoma is treated with a combination of chemotherapy and the monoclonal antibody rituximab (chemoimmunotherapy). Following ...

  4. Treatment

    Cutaneous B-cell lymphoma treatment depends on the specific type of lymphoma that you have. Treatment options may include: Radiation therapy. Radiation ...

  5. An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas - Mayo Clinic

    ... lymphomas with CD30 expression that have not responded to treatment or have come back. The subtypes we are studying are Diffuse Large B-Cell Lymphoma (DLBCL) ...

  6. A Study Investigating the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    ... B-cell non-Hodgkin lymphoma (NHL), and in previously untreated participants with diffuse large B-cell lymphoma (DLBCL). Participation eligibility.

  7. A Trial to Evaluate the Efficacy and Safety of MOR208 With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) - Mayo Clinic

    ... B-cell Lymphoma (DLBCL). Print details. Share; Facebook · Twitter. Overview ... RTX and BEN are both approved in many countries for the treatment of lymphomas.

  8. Combination Chemotherapy or 90-Yttrium Ibritumomab Tiuxetan and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Relapsed Diffuse Large B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    ... cell transplant are more effective than BEAM alone in treating patients with diffuse large b-cell non-Hodgkin lymphoma. Participation eligibility.

  9. Diagnosis

    Tests and procedures used to diagnose cutaneous B-cell lymphoma include: ... The sample is tested in a lab to look for lymphoma cells. Blood tests. A ...

  10. Lisocabtagene maraleucel (intravenous route) - Mayo Clinic

    Lisocabtagene maraleucel injection is used to treat large B-cell lymphoma ... cells, which have been modified to recognize and attack your cancer cells.